Solvay (SOLB) Aktienübersicht
Solvay SA bietet weltweit Basis- und Veredelungschemikalien an. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 2/6 |
| Künftiges Wachstum | 4/6 |
| Vergangene Leistung | 1/6 |
| Finanzielle Gesundheit | 3/6 |
| Dividenden | 3/6 |
Belohnungen
Risikoanalyse
SOLB Community Fair Values
Create NarrativeSee what 46 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
ST
stuart_roberts
Community ContributorCA$5.07FV • 68.6% unterbewertet intrinsischer Abschlag
4849.4%Revenue growth p.a.
13.3k
37
1
271
Solvay SA Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | €27.90 |
| 52-Wochen-Hoch | €34.52 |
| 52-Wochen-Tief | €23.54 |
| Beta | 0.24 |
| 1 Monat Veränderung | 5.44% |
| 3 Monate Veränderung | 12.50% |
| 1 Jahr Veränderung | -16.42% |
| 3 Jahre Veränderung | -73.15% |
| 5 Jahre Veränderung | -75.23% |
| Veränderung seit IPO | 0.49% |
Aktuelle Nachrichten und Updates
SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others. Analyst Commentary Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance.SOLB: Trimmed Expectations And Mixed Ratings Will Still Support Fair Value
Solvay's analyst price target has been trimmed by about €0.25, as analysts factor in softer revenue expectations, slightly higher margin assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research on Solvay points to a cautious stance, with several firms trimming price targets or downgrading ratings while a few still see upside at specific levels.SOLB: Rare Earth Role Will Offset Execution Risks And Support Fair Value
Analysts have nudged Solvay's fair value estimate slightly lower to about €25.72 per share. This reflects a mix of reduced profit margin assumptions, a modestly lower discount rate, and updated external price targets that now cluster in the €22 to €28 range.SOLB: Rare Earth Supply Role Will Temper Softer Outlook And Downgrades
Narrative Update on Solvay Our updated analyst price target for Solvay edges down slightly to €25.78 from €25.88. This reflects a modest recalibration of expected growth and margins, even as recent Street research has shifted targets in a tight €22 to €28 range with several downgrades and cautious P/E assumptions from analysts.Recent updates
SOLB: Mixed Ratings And Slightly Lower Assumptions Will Shape Fair Value Outlook
Solvay's analyst price target has edged down by about €0.13 as analysts adjust their fair value and P/E assumptions, reflecting recent target moves and downgrades from several banks while still incorporating some upward revisions from others. Analyst Commentary Recent research updates show a split view on Solvay, with some analysts lifting price targets while several others cut targets or downgraded their stance.SOLB: Trimmed Expectations And Mixed Ratings Will Still Support Fair Value
Solvay's analyst price target has been trimmed by about €0.25, as analysts factor in softer revenue expectations, slightly higher margin assumptions and a lower future P/E multiple. Analyst Commentary Recent Street research on Solvay points to a cautious stance, with several firms trimming price targets or downgrading ratings while a few still see upside at specific levels.SOLB: Rare Earth Role Will Offset Execution Risks And Support Fair Value
Analysts have nudged Solvay's fair value estimate slightly lower to about €25.72 per share. This reflects a mix of reduced profit margin assumptions, a modestly lower discount rate, and updated external price targets that now cluster in the €22 to €28 range.SOLB: Rare Earth Supply Role Will Temper Softer Outlook And Downgrades
Narrative Update on Solvay Our updated analyst price target for Solvay edges down slightly to €25.78 from €25.88. This reflects a modest recalibration of expected growth and margins, even as recent Street research has shifted targets in a tight €22 to €28 range with several downgrades and cautious P/E assumptions from analysts.SOLB: Rare Earth Supply Role Will Offset Softer Outlook And Downgrades
Analysts have reduced their price target on Solvay to about €25.88 from roughly €26.44, reflecting a series of recent downgrades and slightly softer assumptions for revenue, margins and fair value multiples. Analyst Commentary Bullish Takeaways Bullish analysts still see upside to the current share price, with some targets such as €28 and €27 implying room for rerating if execution on cost discipline and portfolio focus holds up.SOLB: Rare Earth Partnerships Will Counter Softer Outlook And Cautious Ratings
Analysts have trimmed their price targets on Solvay, with our fair value estimate moving from €27.19 to €26.44 as they factor in slightly softer revenue expectations, a higher discount rate, and lower assumed future P/E multiples, partly offset by firmer profit margin assumptions. Analyst Commentary Recent Street research on Solvay has leaned more cautious, with several firms lowering price targets and moving to more neutral or negative ratings as they reassess the risk and reward profile.SOLB: Rare Earth Agreements Will Offset Softer Outlook At A Fair Price
Analysts have nudged their Solvay price target slightly lower to about €27.19 from about €27.27, reflecting updated views on slower revenue trends, a higher discount rate, better profit margins, and a lower future P/E assumption, alongside recent target cuts and rating changes from several research houses. Analyst Commentary Recent research opinions around Solvay cluster around cautious updates to price targets and ratings, with most commentary focusing on how current execution and growth expectations line up against existing valuations.SOLB: Rare Earth Agreements Will Steady Execution Risks At A Fair Price
Analysts have trimmed their price target on Solvay to about €23.50, a modest reset that reflects slightly lower profit margin expectations while keeping fair value and P/E assumptions broadly in line with prior views. Analyst Commentary Recent research points to a slightly lower fair value marker for Solvay at about €23.50, which still sits close to prior assumptions on P/E and overall valuation.SOLB: Rare Earth Agreements Will Offset Softer Outlook And Heightened Execution Risks
Analysts trimmed their fair value estimate for Solvay by about EUR 0.50 per share, reflecting slightly higher perceived risk and softer long term growth expectations, in line with a series of recent price target cuts across the Street. Analyst Commentary Recent Street updates reflect a cautious stance on Solvay, with a series of modest price target reductions signaling tempered expectations for both earnings growth and valuation upside.SOLB: Near-Term Outlook Will Hinge On Margin Resilience Amid Industry Pressures
Solvay’s analyst price target was modestly reduced from €27.80 to €27.73. Analysts cite ongoing cautiousness around revenue growth and margin pressures, which are reflected in several recent downward revisions.SOLB: Future Performance Will Depend On Profit Margin Recovery And Cost Discipline
Solvay's analyst price target was reduced from €28.70 to €27.80, as analysts cited a more cautious outlook on revenue growth and profit margins in recent research updates. Analyst Commentary Analyst sentiment toward Solvay has shifted in recent research updates, with several firms lowering their price targets and highlighting both positive and negative drivers that could influence the company’s near-term performance.SOLB: Recent Macroeconomic Pressures Will Shape Outlook Amid Stable Fundamentals
Narrative Update on Solvay Solvay’s analyst price target has been lowered slightly, from €28.97 to €28.70, as analysts cite modestly higher discount rates and slightly weaker revenue growth outlooks in their recent updates. Analyst Commentary Recent updates from analysts have provided a nuanced view of Solvay's outlook, highlighting both areas of potential and ongoing challenges that may affect its future performance.La Rochelle Expansion And Energy Transition Will Secure Future Success
Analysts have modestly reduced their price target for Solvay, lowering it by a small margin in response to recent Street research. The research cites softer profit margins and ongoing revenue pressures, resulting in updated targets between EUR 25.50 and EUR 27.La Rochelle Expansion And Energy Transition Will Secure Future Success
Solvay's analyst price target has been revised downward by approximately EUR 0.80 per share. Analysts cite ongoing revenue pressure and updated profit margin forecasts to support the adjustment.La Rochelle Expansion And Energy Transition Will Secure Future Success
Analysts have maintained a cautious outlook on Solvay due to persistent input cost inflation, margin pressure, and weak European demand, resulting in conservative earnings estimates and an unchanged consensus price target of €29.83. Analyst Commentary Cautious sentiment persists due to slower organic growth outlook in core businesses.Risks To Shareholder Returns Are Elevated At These Prices For Solvay SA (EBR:SOLB)
Jan 24
Solvay (EBR:SOLB) Will Pay A Dividend Of €0.679
Jan 06
Green River Expansion And Hydrogen Peroxide Licensing Propel Earnings Growth
Expansion of Green River facility and sustainability efforts position Solvay to benefit from future revenue growth and attract environmentally conscious customers.Solvay's (EBR:SOLB) Dividend Will Be €0.679
Dec 21Solvay SA (EBR:SOLB) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Oct 17Are Investors Undervaluing Solvay SA (EBR:SOLB) By 43%?
Sep 18Solvay SA's (EBR:SOLB) Share Price Could Signal Some Risk
Aug 28Solvay's (EBR:SOLB) Earnings May Just Be The Starting Point
Aug 08Solvay (EBR:SOLB) Has A Somewhat Strained Balance Sheet
Jul 14Are Investors Undervaluing Solvay SA (EBR:SOLB) By 37%?
Jun 14Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
May 29Solvay SA (EBR:SOLB) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Apr 24Solvay SA's (EBR:SOLB) Business And Shares Still Trailing The Market
Mar 10Is Solvay SA (EBR:SOLB) Trading At A 28% Discount?
Nov 20Solvay (EBR:SOLB) Is Increasing Its Dividend To €1.13
Nov 06The Return Trends At Solvay (EBR:SOLB) Look Promising
Nov 02Here's Why Solvay (EBR:SOLB) Can Manage Its Debt Responsibly
Oct 19Is It Too Late To Consider Buying Solvay SA (EBR:SOLB)?
Aug 16Returns At Solvay (EBR:SOLB) Are On The Way Up
Aug 02Is Solvay (EBR:SOLB) A Risky Investment?
Jul 19An Intrinsic Calculation For Solvay SA (EBR:SOLB) Suggests It's 26% Undervalued
Jul 06Aktionärsrenditen
| SOLB | BE Chemicals | BE Markt | |
|---|---|---|---|
| 7D | 0.9% | 0.9% | 0.1% |
| 1Y | -16.4% | 2.3% | 19.4% |
Rendite im Vergleich zur Industrie: SOLB unter dem Niveau der Branche Belgian Chemicals , die im vergangenen Jahr eine Rendite von 2.3% erzielte.
Rendite vs. Markt: SOLB hinter dem Markt Belgian zurück, der im vergangenen Jahr eine Rendite von 19.4 erzielte.
Preisvolatilität
| SOLB volatility | |
|---|---|
| SOLB Average Weekly Movement | 4.1% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in BE Market | 7.4% |
| 10% least volatile stocks in BE Market | 2.6% |
Stabiler Aktienkurs: SOLB hatte in den letzten 3 Monaten im Vergleich zum Belgian -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: SOLBDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1863 | 8,331 | Philippe Kehren | www.solvay.com |
Solvay SA bietet weltweit Basis- und Veredelungschemikalien an. Das Unternehmen stellt Natriumcarbonat oder Soda her, das in Bauglas, Solarpanelen, Glasbehältern, Verpackungen, Lithium-Ionen-Batterien für Elektrofahrzeuge sowie in Waschmitteln und Chemikalien verwendet wird. Außerdem produziert es Natriumbicarbonat, das in der Lebensmittel- und Tierfutterindustrie, der Rauchgasreinigung und im Gesundheitswesen eingesetzt wird.
Solvay SA's Grundlagenzusammenfassung
| SOLB grundlegende Statistiken | |
|---|---|
| Marktanteil | €2.91b |
| Gewinn(TTM) | €30.00m |
| Umsatz(TTM) | €4.75b |
97.2x
Kurs-Gewinn-Verhältnis 0.6x
Kurs-Umsatz-VerhältnisIst SOLB zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| SOLB Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | €4.75b |
| Kosten der Einnahmen | €3.74b |
| Bruttogewinn | €1.00b |
| Sonstige Ausgaben | €973.00m |
| Gewinn | €30.00m |
Zuletzt gemeldete Gewinne
Dec 31, 2025
Datum des nächsten Gewinnberichts
May 07, 2026
| Gewinn per Aktie (EPS) | 0.29 |
| Bruttomarge | 21.13% |
| Nettogewinnspanne | 0.63% |
| Schulden/Eigenkapital-Verhältnis | 165.5% |
Wie hat sich SOLB auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
8.7%
Aktuelle Dividendenrendite846%
AusschüttungsquoteZahlt SOLB eine zuverlässige Dividende?
Siehe SOLB Dividendenhistorie und Benchmarks| Solvay Dividendentermine | |
|---|---|
| Ex-Dividenden Datum | May 18 2026 |
| Datum der Dividendenzahlung | May 20 2026 |
| Tage bis Ex-Dividende | 16 days |
| Tage bis zum Datum der Dividendenzahlung | 18 days |
Zahlt SOLB eine zuverlässige Dividende?
Siehe SOLB Dividendenhistorie und BenchmarksUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/04/30 16:19 |
| Aktienkurs zum Tagesende | 2026/04/30 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Solvay SA wird von 33 Analysten beobachtet. 11 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Robert Bate | Barclays |
| Katie Richards | Barclays |
| James Stewart | Barclays |